Current Vascular Pharmacology
Title:Editorial (Thematic Issue: Vascular Dysfunction in Obesity and Insulin Resistance)
Volume: 12 Issue: 3
Author(s): Dolores Prieto
Affiliation:
Export Options
About this article
Cite this article as:
Prieto Dolores, Editorial (Thematic Issue: Vascular Dysfunction in Obesity and Insulin Resistance), Current Vascular Pharmacology 2014; 12 (3) . https://dx.doi.org/10.2174/157016111203140518154828
DOI https://dx.doi.org/10.2174/157016111203140518154828 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insulinoma Case Admitted with Reactive Hypoglycemia Symptoms
Current Diabetes Reviews Phage Display as a Tool for Protease Ligand Discovery
Current Pharmaceutical Biotechnology Diagnosis and Management of Chronic Coronary Artery Disease
Current Cardiology Reviews Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry EBI2, GPR18, and GPR17 – Three Structurally Related but Biologically Distinct 7TM Receptors
Current Topics in Medicinal Chemistry Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice
Current Drug Safety Pre-Emptive Conditioning of the Ischemic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Apoptosis in Atherosclerosis: A Mini-Review
Mini-Reviews in Medicinal Chemistry Hypertension and Cardiac Arrhythmias
Current Pharmaceutical Design Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure
Current Cardiology Reviews MicroRNAs in the Management of Heart Failure
Current Medicinal Chemistry Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction
Current Hypertension Reviews Refined Echocardiographic Assessment and Contemporary Medical Treatment of Obstructive Hypertrophic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Anti-atherosclerotic Effects of Spice-Derived Phytochemicals
Current Medicinal Chemistry Cardiovascular Adverse Effects of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Mesenchymal Stem Cells in Immune Response
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) In-Vivo Gene Delivery by Sonoporation: Recent Progress and Prospects
Current Gene Therapy The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model
CNS & Neurological Disorders - Drug Targets Local Delivery of Therapeutics for Percutaneous Coronary Intervention
Current Drug Delivery